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KEY POINTS
 Resection of nonpolypoid lesions in inflammatory bowel disease (IBD) is among the most
technically demanding of endoscopic procedures.
 Inflammation and submucosal fibrosis make lesion preassessment and lifting difficult.
 En bloc excision is preferred where possible with snare or endoscopic submucosal
dissection (ESD) to optimize the pathologic specimen and reduce recurrence risk.
 Close follow-up of the resection site and whole colon with dye-spray is required
postresection.Video of Endoscopic Submucosal Dissection (ESD) of a non-polypoid dysplastic
lesion in ulcerative colitis accompanies this article at http://www.giendo.
theclinics.com/INTRODUCTION
The risk of developing IBD-colitis-related colorectal cancer has been highlighted for
many years. Early data suggested that the risk increased year on year with an 18%
risk at 30 years1 and the initial British guidelines advocating shortening of surveillance
intervals with each decade of disease.2 Subsequent data suggested the stronger in-
fluence of patient factors, including disease extent and activity, family history of colo-
rectal cancer, endoscopic features (strictures or postinflammatory polyps) and
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East et al436of European guidelines advocating risk-based stratification.3–5 More recently, some
population-based studies have suggested that previous results overestimate the
risk of IBD dysplasia and cancer because of case selection from academic and tertiary
centers.6,7
Alongside risk-based stratification, a new concept emerged for the management of
polypoid dysplasia in IBD, in that polypoid circumscribed lesions (adenoma like
masses) even within the colitic segment, might be safely managed by endoscopic
resection and close follow-up rather than by panproctocolectomy.4,5 A recent
meta-analysis of 10 studies with more than 370 patients and 1700 years of patient
follow-up supports this concept: 5 (95% confidence interval, 3–10) cancers devel-
oped per 1000 years of patient follow-up.8 The rate of dysplasia detected at subse-
quent colonoscopy was 65 cases per 1000 years of patient follow-up, emphasizing
that close colonoscopic surveillance is mandatory. However, all the studies in this
meta-analysis predate the use of chromoendoscopy. The need for proctocolectomy
when dysplasia is detected in IBD is based on older data, which suggested a 19%
cancer rate at immediate proctocolectomy when low-grade dysplasia was detected
and as much as 42% when high-grade dysplasia was found.9 These data almost
certainly related to a previous generation of endoscopes and endoscopists, the latter
being less familiar than present-day endoscopists are with the appearances of non-
polypoid colorectal neoplasms, dysplasia, and cancer in IBD and hampered by a
lack of high-quality endoscopic imaging. Furthermore, these endoscopists did not
enjoy the advantages of high-definition, wide-angle endoscopes and dye-spray or
image-enhanced endoscopy including structure enhancement, narrow-spectrum
endoscopy (narrow band imaging [NBI, Olympus, Tokyo, Japan], Fujinon intelligent
chromoendoscopy [FICE, Fujinon, Tokyo, Japan], i-Scan, image-enhanced endos-
copy [Pentax, Tokyo, Japan]), autofluorescence, or confocal endomicroscopy (see
the article on advanced imaging elsewhere in this issue). Therefore, dysplasia
detected in the current era of endoscopes and endoscopists is likely to be at an early
stage and can be safely managed by endoscopic resection if polypoid and
circumscribed.
However, not all dysplasia detected at endoscopy in IBD is polypoid. The concept of
flat dysplasia or endoscopically invisible dysplasia, detectable only by random
biopsies has been commonly accepted, particularly in the prechromoendoscopy
era, leading to previous generations of guidelines advocating the use of quadratic
biopsies every 10 cm of colonoscopic withdrawal to detect this invisible dysplasia.
This recommendation is poor for detection of early dysplasia, with one simulation pa-
per based on colonic surface areas and dysplasia size suggesting that the standard 32
nontargeted biopsies would only detect an area of dysplasia encompassing 5% or
more of the colonic surface with 80% certainty.10 The use of the word flat for biopsy-
only-detected dysplasia is unfortunate because this word has also been used to
describe nonpolypoid dysplasia in the endoscopic literature as part of the Paris classi-
fication.11 Flat or nonpolypoid in the endoscopic literature corresponds to Paris 0-IIa,
flat elevated lesion; Paris 0-IIb, completely flat lesions; and Paris 0-IIc, depressed le-
sions. Many instances of patients diagnosed with flat biopsy-only dysplasia can be
converted to circumscribed areas of dysplasia described as Paris 0-IIa, IIb, or IIc by
reexamination with meticulous bowel preparation, with the patient in full remission,
with an experienced endoscopist familiar with dysplasia in IBD, and with the use of
high-definition endoscopes with dye-spray and image enhancement. If one accepts
that circumscribed areas of flat dysplasia may be safely endoscopically resected
with close endoscopic surveillance afterward,12 a concept that is by nomeans proven,
then one needs to consider the special circumstances of how to safely and
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focus of this review.
APPROACH TO RESECT NONPOLYPOID DYSPLASIA IN IBD
The resection of mucosal dysplasia in the gastrointestinal tract requires a series of
steps to be safe and effective, which are outlined in Box 1. Here, it is assumed that
an isolated, ie, nonmultifocal, nonpolypoid (Paris 0-IIa, 0-IIb, or 0-IIc), lesion within
a colitic segment has been detected; that the patient’s case has been discussed at
an IBD multidisciplinary team meeting with a recommendation for attempt at endo-
scopic resection; and that the patient, having discussed the pros and cons of an endo-
scopic approach and being informed of the risks and benefits, is willing to proceed.
Furthermore, it is also assumed that as far as possible the patient is in remission
from colitis and that the bowel is optimally prepared. Data on approach to these
lesions are scarce and predominantly based on expert end consensus opinion,
extrapolation from first principles, and from experiences with resection of dysplastic
lesion in noncolitic colons in situations that may mimic colitis-related fibrosis, such
as scarring from previous endoscopic resection or nongranular-type laterally
spreading tumors (LSTs). By definition, endoscopic resection of dysplasia in colitis
is at the far end of the spectrum of difficulty of endoscopic resection and should
only be attempted by experienced, usually specialist endoscopists, with appropriate
experience of advanced endoscopic mucosal resection (EMR), case volume, and anBox 1
Approach to resect nonpolypoid dysplasia in IBD
 Lesion assessment
 Extent
 Risk of invasion
 Associated structures, eg, ileocecal valve
 Scarring
 Endoscopic access
 Lifting
 Mucosal inflammation/scarring
 Special lift solution, eg, hyaluronate
 Resection
 Endoscopic mucosal resection
- En bloc
- Piecemeal
 Endoscopic submucosal dissection
 Special snares (spiral or flat band/ribbon)
 Ablation
 Argon plasma coagulation
 Snare tip soft coagulation
 Follow-up
 Scar assessment
East et al438endoscopic support team with surgical backup. Such cases might usually be referred
to tertiary or regional specialists.
Lesion Assessment
A nonpolypoid dysplastic lesion in IBD needs to first be carefully examined. Thus,
before considering an attempt at endoscopic resection and weighing the associated
technical risks of bleeding, perforation, and postpolypectomy syndrome, as well as
the ensuing risk of cancer within the resection specimen and recurrence, the lesion
characteristics must be interpreted. The first question to be addressed is lesion bor-
ders and extent. Endoscopic resection is only appropriate for lesions that have clearly
defined borders (ie, circumscribed). Enhancement of the edges of these subtle lesions
can be helped by the use of dye-spray or advanced imaging techniques. If a clear
margin of the lesion cannot be seen, it is unlikely that endoscopic resection is appro-
priate because there is significant risk that residual dysplasia will be left in situ (Fig. 1).
Even if a clear border can be seen, it is appropriate to perform biopsies around the
lesion to look for endoscopically invisible dysplasia before committing to resection.
Ideally, only a single biopsy of the lesion itself would be done to avoid welding the
lesion to the submucosa even further through biopsy-associated fibrosis. The authors’
personal preference is to use a high-definition endoscope, ideally with optical magni-
fication, and chromoendoscopy and surface enhancement for this process.
Assuming the lesion has a clear edge with no surrounding dysplasia on biopsy of
macroscopically normal mucosa, the lesion should be completely clear of stool and
mucus andminutely examined for risks of invasion. Suspicious aspects include a large
nodule, depression and loss of pit pattern, and a masslike appearance (Fig. 2).13 The
presence of any of these signs should lead to a careful consideration of whether endo-
scopic resection is appropriate. Unfortunately, these techniques, which are reason-
ably reliable in noncolitic colons, perform less well in colitis, because the scarring
may lead to pseudodepression and inflammation distorts pit patterns. The nonlifting
sign, which in combination with macroscopic appearance gives a good estimate of
likely invasion in the assessment of noncolitis-associated lesions, is by definition
poor in colitis. Submucosal scarring impedes mucosal lift14 and also disrupts the
mucosal layers needed to clearly assess invasion at endoscopic ultrasonography. In
noncolitis cases, submucosal scarring can be seen in lesions with a previous attempt
at resection, recurrence on a scar from previous EMR, or nongranular type LSTs.15 InFig. 1. This endoscopic image shows a nonpolypoid flat dysplastic area in the lower region
of rectum (A). Despite use of dye-spray, a clearly circumscribed boarder cannot be delin-
eated (B). Therefore, this lesion is not suitable for endoscopic resection.
Fig. 2. This 15-mm lesion in the rectum of a 71-year-old woman with ulcerative colitis was
selected for ESD. Note that the pit pattern is difficult to interpret and that it suggests a nodule
or mass lesion (Paris 0-Is component), raising suspicion for invasion (A, B). En bloc excision was
achieved with ESD; the histology showed early invasion (Kikuchi stage sm1) (C, D).
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matory polyps, loss of vascular pattern, or active inflammation, the submucosal scar-
ring is likely to be severe and typically involves the entire lesion.
Location of the lesion near technically difficult areas such as the appendix orifice,
ileocecal valve, at a flexure, especially on the inside of the bend, and at the anal verge
should also be considered.16 Although polyps in all these positions can be resected in
noncolitic colon by experienced endoscopists, the technical difficulty is substantially
increased. In combination with the other inherent challenges that colitic lesions pre-
sent, this may make the likelihood of a successful resection so low that an endoscopic
attempt is not appropriate.
The final stage is to consider endoscopic access. This is one of the few areas in
which working in a colitic colon may have advantages because a scarred and tubular
colon makes for a straight endoscope and associated accurate tip movements and a
lack of haustral folds to be negotiated. Before starting, endoscopists should be satis-
fied that they can easily reach all areas of the lesion with submillimeter precision.
There is no specific combination of factors or scoring system that suggests that le-
sions are or are not safely and effectively resectable. Ultimately, at least at present, it
East et al440comes down to the experience and judgment of the assessing endoscopist. Given the
fine nature of these judgments, the authors recommend that if possible the endoscop-
ist who is going to do the resection procedure should perform the endoscopy for
lesion assessment before resection.
Lifting
Lifting or the failure of lifting of lesions in colitis is one of the major obstacles to resec-
tion. This leads to problems with lesion assessment for invasion as outlined above, but
more importantly means that the lesion cannot be safely lifted away from the underly-
ing muscularis propria to allow a safe plane for the snare or endoscopic knife to tra-
verse for resection. The scarring in the submucosa means that there is difficulty in
finding the submucosal plane, a failure to lift, a ‘diffuse’ lift in which fluid tracks laterally
rather than resulting in focal elevation, and a rapid loss of any lift achieved. Techniques
to counter these problem include the use of the dynamic injection technique,17 the use
of thinner-bore injection needles (25 G rather than 21 G or 23 G), and the use of more
viscous and longer-lasting injection solutions including colloids, eg, gelofusine,18 or
sodium hyaluronate.19 Other viscous solutions, eg, hypromellose or glycerol, might
also be considered.19 Nevertheless, even with these advantages, lift in colitic lesions
is often suboptimal.
Resection
En bloc resection of the lesion is preferable to allow precise pathologic assessment
and minimize residual dysplasia or recurrence. ESD offers this possibility and is tech-
nically possible in colitis. However, the comprehensive submucosal fibrosis increases
the procedural risks and reduces R0 resection rates even for superspecialist experts in
ESD (Figs. 3 and 4). Use of small-caliber-tip transparent hoods can help in severe
fibrosis, and there is often a need to use sharp-tipped needle knives to cut fibrotic
bands, albeit at the risk of a loss of hemostatic capacity (Video 1).20
The adaptation of ESD concepts may offer some advantages to less-experienced
Western endoscopists. Two concepts may be helpful.21 The first is the so-called
Endoscopic Mucosal Resection with snaretip incision (SI) that can be possible for
smaller lesions up to 20 mm in which submucosal scarring is not so severe and
some lift is possible. Here, after lifting, the snare tip is used to make a small incision
on the oral side of the lesion. This small hole is used to anchor the snare tip to allow
definite edge capture and additional downward pressure with the snare in a situation
of limited lift, increasing the chances on an en bloc snare resection. The second is the
use of mucosal incision, the first step in full ESD.21 Here the use of an endoknife to
carefully incise a groove around the lesion is performed before an attempt at conven-
tional en bloc or piecemeal EMR. The edge of the snare is then placed in this marginal
groove for resection. Both these concepts improve grip on the lesion edge by the
snare and allow a clean resection margin at the edge of the lesion. In colitis, once
resection starts, the lesion margin can be difficult to see, so marginal incision can
assist here as well. This procedure is sometimes described as simplified or hybrid
ESD and in some situations represents a good compromise between the time, risk,
and difficulty of full ESD, yet fulfills the need for resection with a clear margin.
Snares
Standard snares can be used for EMR in colitis; however, as alluded to above,
scarred, flat lesions with poor lift can be difficult to engage into the snare. Furthermore,
if a large piece is successfully engaged, there is a risk that the scarring will pull up an
area of underlying muscle leading to damage to the muscularis propria target sign or a
Fig. 3. A 20-mm nonpolypoid (Paris 0-IIa) lesion was found in the midrectum of a 53-year-old
patient, with circumscribed edges after dye-spray (A). Marking was used to define the lesion
edges clearly before mucosal incision. Although commonly used in ESD in the upper gastro-
intestinal tract, marking is rare in the colon; however, because of the subtle edges of the
lesion, this may be helpful in colitis (B). A formal ESD is performed with en bloc excision (C,
D) with the resected specimen showing clear margins (E). Pathology confirmed low-grade
dysplasia.
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cosa. Braided or spiral snares may be used, which have an additional spiral wire
around the main snare cable, to improve gripping (spiral snare 20 mm, SnareMaster,
Olympus, Tokyo, Japan). An alternative is the flat band or ribbon snare (flat ribbon
snare 22 m, Resection Master, Medwork, Ho¨chstadt, Germany). This snare comprises
Fig. 4. (A, B) A 50-mmnonpolypoid lesion in themidrectumof a patientwith ulcerative colitis
was scheduled for an attempt at resection by ESD. Intense fibrosis was observed in the submu-
cosal layer (yellow-white band under mucosal flap) making resection very challenging.
Fig. 5. A 35-mm nonpolypoid (Paris 0-IIa) lesion was detected in the cecum of a patient with
long-standing pancolonic IBD (A). Use of dye-spray confirms a circumscribed lesion without
high-risk features (B). Narrow band imaging is used to assess the microvessel network (C).
The lesion is resected in 4 fragments by piecemeal EMR with a 10-mm snare (D). All frag-
ments are retrieved with a Roth net for pathology assessment (E). Pathology confirms a
tubulovillous adenoma with low-grade dysplasia (F) (Hematoxylin and eosin, original
magnification 400). Reassessment of the scar after healing with dye-spray showed no
dysplasia either macroscopically or in scar biopsies (G).
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cally to the mucosa. An alternative is to use a smaller braided snare to resect small
pieces at a time, reducing the risk that too much mucosa is gathered with associated
muscle, as one might do for a scarred lesion in noncolitic colons (Fig. 5). A final option
is the use of a double-channel endoscope using a grasper to pull the mucosa into a
snare, which is in the other channel. Although this technique guarantees the ability
to grip the mucosa, the risk of perforation is significantly magnified, and experience
and extreme care are needed.Ablation
Owing to the scarring in colitis, the nature of resection of colitic lesions often entails
piecemeal resection. Every attempt should be made to endoscopically resect any
visible part of the lesion. However, piecemeal resection coupled with significant
scaring may result in fragments or islands of dysplasia left at the resection site.
Such areas need to be definitively but safely destroyed. Argon plasma coagulation
(APC) has been commonly used for this with some evidence from the EMR literature
that it is effective in reducing recurrence.23 (Many EMR experts suggest that the
need for this in noncolitic colons is now unnecessary because the EMR technique
has improved; however, older, less-comprehensive EMR to some extent mimics the
results in colitis so the two may be comparable.) Precise use of short pulses of APC
is effective even for larger areas. Further attempts at injection before use of APC
East et al444may allow the so-called melt effect seen with the use of APC for dysplasia ablation in
the duodenum.24 For small fragments, the use of the tip of the snare with soft coagu-
lation allows effective ablation without overdelivery of energy and risks of a deep
mucosal burn. Ultimately, the optimum is en bloc R0 snare or ESD resection with path-
ologic assessment of resected tissue. Ablation should be minimized.
Follow-Up
After resection, which should be as complete as possible at the first attempt, careful
examination of the scar should be performed at between 2 and 6 months postresec-
tion, as well as pancolonic dye-spray of the whole colon to look for metachronous
lesions. The use of dye-spray and advanced imaging on the scar can be helpful
here to try and detect tiny areas of recurrence. Scar biopsy should be performed
even if there is no recurrence. If recurrence is suspected, and the threshold should
be low, a biopsy of the site followed by the ablation methods mentioned above is
appropriate, with a further examination in 2 to 6 months. Repeated recurrence
despite appropriate ablation, high-grade dysplasia in recurrence biopsies, or a large
area of recurrence should prompt consideration of surgical resection or ESD
salvage.SUMMARY
Safe and comprehensive resection of nonpolypoid dysplasia in IBD is demanding both
in terms of diagnostic judgments preresection and of technical skills during the resec-
tion. Good outcomes require meticulous planning and maximizing potential technical
advantages, with an aim to achieve en bloc excision where possible. The safe resec-
tion of circumscribed nonpolypoid dysplasia in IBD is possible by an appropriately
trained endoscopic team and may avoid the need for colectomy.SUPPLEMENTARY DATA
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